Major telehealth providers and industry groups pushed for expanded access to controlled substance prescribing via telemedicine during a Drug Enforcement Administration listening session held Tuesday.
Ganny Belloni is a reporter for Bloomberg Law, covering a wide range of topics in the healthcare industry. With a focus on legal and policy issues, Ganny's articles provide insights into the latest developments and controversies surrounding healthcare regulations, Medicaid, Medicare, and telehealth.